World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 November 2015
Main ID:  NCT02431377
Date of registration: 07/04/2015
Prospective Registration: No
Primary sponsor: Nestlé
Public title: Acceptability and GI Tolerance of an Alpha-lactalbumin-enriched Formula
Scientific title: Acceptability and GI Tolerance of an Alpha-lactalbumin-enriched Formula: An Uncontrolled, Open-label, Descriptive Study
Date of first enrolment: April 2015
Target sample size: 40
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02431377
Study type:  Interventional
Study design:  Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label  
Phase:  N/A
Countries of recruitment
Philippines
Contacts
Name:     Elvira M Estorninos, MD
Address: 
Telephone:
Email:
Affiliation:  Asian Hospital and Medical Center
Key inclusion & exclusion criteria

Inclusion Criteria:

1. Written informed consent

2. Healthy, full term, singleton infant

3. Be between 28±7 days post-natal age

4. Infants at enrollment, weight-for-age = 5th and = 95th percentile according to World
Health Organization growth tables / charts

5. Infants must be exclusively consuming and tolerating a cow's milk infant formula for
a minimum of 3 consecutive days and parent(s)/LAR must have previously made the
decision to continue to exclusively formula feed

6. Have sufficient command of Tagalog or English language to complete the informed
consent and other study documents

7. Are willing and able to fulfill the requirements of the study protocol

8. Have reached the legal age of consent in the Philippines

9. Able to be contacted by telephone throughout the study

Exclusion Criteria:

1. Infants who are receiving any amount of supplemental human milk

2. Family history of siblings with documented cow's milk protein intolerance/allergy

3. Conditions requiring infant feedings other than those specified in the protocol



Age minimum: N/A
Age maximum: 35 Days
Gender: Both
Health Condition(s) or Problem(s) studied
Infant Formula Intolerance
Intervention(s)
Other: S-26 Gold
Primary Outcome(s)
Infant Gastrointestinal Symptom Questionnaire Composite Index Score [Time Frame: 6 weeks]
Secondary Outcome(s)
Infant Toddler Quality of Life Profile [Time Frame: 6 weeks]
Stool Consistency Score [Time Frame: 6 weeks]
Infant Characteristics Questionnaire (ICQ) Profile [Time Frame: 6 weeks]
Baby Eating Behaviour Questionnaire Profile [Time Frame: 6 weeks]
Formula Intake volume [Time Frame: 6 weeks]
Secondary ID(s)
14.23.INF
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history